Zymeworks Inc.ZYMENASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P44
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-2.55%
Q3 2025-5.37%
Q2 2025-12.35%
Q1 20254.94%
Q4 202416.55%
Q3 2024-11.46%
Q2 20241208.33%
Q1 2024-91.88%
Q4 2023-13.08%
Q3 2023-21.69%
Q2 202328.09%
Q1 2023-46.62%
Q4 202299.76%
Q3 20224.27%
Q2 202226.37%
Q1 2022107.79%
Q4 2021-62.41%
Q3 2021-22.60%
Q2 20211522.20%
Q1 2021-90.62%
Q4 2020-40.24%
Q3 202069.73%
Q2 202080.20%
Q1 2020-76.41%
Q4 2019149.78%
Q3 2019-4.61%
Q2 201941.74%
Q1 201943.00%
Q4 2018-15.46%
Q3 2018-13.89%
Q2 201822.39%
Q1 201849.86%
Q4 2017-10.89%
Q3 2017131.55%
Q2 2017-63.49%
Q1 201722.32%
Q4 201689.80%
Q3 20161.51%
Q2 201627.39%
Q1 201652.08%